Serum YKL-40 is increased in patients with hepatic fibrosis

Journal of Hepatology

Volumn 32, Issue 6, 2000, Pages 911-920

  Johansen, Julia S ^b   Christoffersen, Per ^c   Møller, Søren ^c   Price, Paul A ^a   Henriksen, Jens H ^c   Garbarsch, Charly ^c   Bendtsen, Flemming ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Julia S Johansen   (Denmark)

^c NONE

Author keywords

Alcoholic liver disease; HC gp 39; Liver fibrogenesis; Liver fibrosis; YKL 40

Indexed keywords

CHITINASE; PROTEIN YKL 40; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CONTROLLED STUDY; FATTY LIVER; FIBROGENESIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FAMILY;

EID: 0034041067     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80095-1     Document Type: Article

References (51)

1. Bissell DM, Roll J. Connective tissue metabolism and hepatic fibrosis. Zakim D, Boyer TD. Hepatology. 1990;424-444 W.B. Saunders Company, Philadelphia, London, Toronto.
2. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med. 328:1993;1828-1835.
3. Gressner AM. Liver fibrosis: perspectives in pathobiochemical research and clinical outlook. Eur J Clin Chem Clin Biochem. 29:1991;293-311.
4. Johansen JS, Jensen HS, Price PA. A new biochemical marker for joint injury. Analysis of YKL-40 in serum and synovial fluid. Br J Rheumatol. 32:1993;949-955.
5. Hakala BE, White C, Recklies AD. Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem. 268:1993;25803-25810.
6. Hu B, Trinh K, Figueira WF, Price PA. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem. 271:1996;19415-19420.
7. Krause SW, Rehli M, Kreutz M, Schwarzfischer L, Paulauskis JD, Andreesen R. Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol. 60:1996;540-545.
8. Rejman JJ, Hurley WL. Isolation and characterization of a novel 39 kilodalton whey protein from bovine mammary secretions collected during the nonlactating period. Biochem Biophys Res Commun. 150:1988;329-334.
9. Nyirkos P, Golds EE. Human synovial cells secrete a 39 kDa protein similar to a bovine mammary protein expressed during the non-lactating period. Biochem J. 268:1990;265-268.
10. Johansen JS, Williamson MK, Rice JS, Price PA. Identification of proteins secreted by human osteoblastic cells in culture. J Bone Miner Res. 7:1992;501-512.
11. Morrison BW, Leder P. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene. 9:1994;3417-3426.
12. Shackelton LM, Mann DM, Millis AJT. Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem. 270:1995;13076-13083.
13. Renkema GH, Boot RG, Au FL, Donker-Koopman WE, Strijland A, Muijsers AO, et al. Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem. 251:1998;504-509.
14. Verheijden GFM, Rijnders AWM, Bos E, Coenen-de Roo CJJ, Van Staveren CJ, Miltenburg AMM, et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum. 40:1997;1115-1125.
15. Rehli M, Krause SW, Andreesen R. Molecular characterization of the gene for human cartilage gp-39 (CHI3L1), a member of the chitinase protein family and marker for late stage macrophage differentiation. Genomics. 43:1997;221-225.
16. Volck B, Price PA, Johansen JS, Sørensen O, Benfield T, Nielsen HJ, et al. YKL-40, a mammalian member of the bacterial chitinase family, is a matrix protein of specific granules in human neutrophils. Proc Assoc Am Assoc Physician. 110:1998;351-360.
17. Johansen JS, Møller S, Price PA, Bendtsen F, Junge J, Garbarsch C, et al. Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis? Scand J Gastroenterol. 32:1997;582-590.
18. Menghini G. One-second biopsy of the liver - problems of its clinical application. N Engl J Med. 283:1970;582-585.
19. Poulsen H, Christoffersen P. Atlas of Liver Biopsies. 1979;Munksgaard, Copenhagen.
20. Johansen JS, Hvolris J, Hansen M, Backer V, Lorenzen I, Price PA. Serum YKL-40 levels in healthy children and adults. Comparison with serum and synovial fluid levels of YKL-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol. 35:1996;553-559.
21. Risteli J, Niemi S, Trivedi P, Mentausta O, Mowat AP, Risteli L. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem. 34:1988;715-718.
22. Brandt R, Hedlöf E, Åsman I, Bucht A, Tengblad A. A convenient radiometric assay for hyaluronan. Acta Otolaryngol (Stockholm). 442:(Suppl):1987;31-35.
23. McCullagh P, Nelder JA. Generalized Linear Models. 2nd ed. 1989;Chapman and Hall, London.
24. Laurent TC, Fraser JRE. Hyaluronan. FASEB J. 6:1992;2397-2404.
25. Gressner AM, Scafer S. Comparison of sulphated glycosaminoglycan and hyaluronate synthesis and secretion in cultured hepatocytes, fat storing cells, and Kupffer cells. J Clin Chem Clin Biochem. 27:1989;141-149.
26. Smedsrød B, Pertoft H, Eriksson S, Fraser JRE, Laurent TC. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J. 223:1984;617-626.
27. Smedsrød B. Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells. Collagen Rel Res. 8:1988;375-388.
28. Engström-Laurent A, Loof L, Nyberg A, Schrøder T. Increased serum levels of hyaluronate in liver disease. Hepatology. 5:1985;638-642.
29. Henriksen JH, Bentsen KD, Laurent TC. Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease. J Hepatol. 6:1988;158-166.
30. Gibson PR, Fraser JRE, Brown TJ, Finch CF, Jones PA, Colman JC, et al. Hemodynamic and liver function predictors of serum hyaluronan in alcoholic liver disease. Hepatology. 15:1992;1054-1059.
31. Guechot J, Poupon RE, Giral P, Balkau B, Giboudeau J, Poupon R. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol. 20:1994;388-393.
32. Pares A, Deulofeu R, Gimenez A, Caballeria L, Bruguera M, Caballeria J, et al. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology. 24:1996;1399-1403.
33. Bentsen KD, Horn T, Risteli J, Risteli L, Engström-Laurent A, Hørslev-Petersen K, et al. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan. Liver. 7:1987;339-346.
34. Ramadori G, Zöhrens G, Manns M, Rieder H, Dienes HP, Hess G, et al. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest. 21:1991;323-330.
35. Hayasaka A, Schuppan D, Ohnishi K, Okuda K, Hahn EG. Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NCl) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease. J Hepatol. 10:1990;17-22.
36. Shahin M, Schuppan D, Waldherr R, Risteli J, Risteli L, Savolainen E-R, et al. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease. Hepatology. 15:1992;637-644.
37. Colombo M, Annoni G, Donato MF, Conte D, Martines D, Zaramella MG, et al. Serum type III procollagen peptide in alcoholic liver disease and idiopathic hemochromatosis: its relationship to hepatic fibrosis, activity of the disease and iron overload. Hepatology. 5:1985;475-479.
38. Bentsen KD, Henriksen JH, Bendtsen F, Hørslev-Petersen K, Lorenzen I. Splanchnic and renal extraction of circulating type III procollagen aminoterminal propeptide in patients with normal liver function and in patients with alcoholic cirrhosis. Hepatology. 11:1990;957-963.
39. Trincher J-C, Hartmann DJ, Pateron D, Laarif M, Gallard P, Ville G, et al. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis: relationship to liver histology and conventional liver tests. J Hepatol. 12:1991;139-144.
40. Savolainen ER, Goldberg B, Leo MA, Velez M, Lieber CS. Diagnostic value of serum procollagen peptide measurements in alcoholic liver disease. Alcohol Clin Exp Res. 8:1984;384-389.
41. Torres-Salines M, Pares A, Caballeria J, Jimenez W, Heredia D, Bruguera M, et al. Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis. Gastroenterology. 90:1986;1241-1246.
42. Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. (review article) Liver. 18:1998;2-13.
43. Iredale JP. Matrix turnover in fibrogenesis. [review] Hepato-Gastroenterology. 43:1996;56-71.
44. Mathew J, Geerts A, Burt AD. Pathobiology of hepatic stellate cells. [review] Hepato-Gastroenterology. 43:1996;72-91.
45. Semino CE, Specht CA, Raimondi A, Robbins PW. Homologs of the Xenopus developmental gene DG42 are present in zebrafish and mouse and are involved in the synthesis of Nod-like chitin oligosaccharides during early embryogenesis. Proc Natl Acad Sci USA. 93:1996;4548-4553.
46. Meyer MF, Kreil G. Cells expressing the DG42 gene from early Xenopus embryos synthesize hyaluronan. Proc Natl Acad Sci USA. 93:1996;4543-4547.
47. Varki A. Does DG42 synthesize hyaluronan or chitin? A controversy about oligosaccharides in vertebrate development. Proc Natl Acad Sci USA. 93:1996;4523-4525.
48. Iozzo RV, Cohen IR, Grässel S, Murdoch AD. The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices. Biochem J. 302:1994;625-639.
49. Roskams T, Moshage H, de Vos R, Guido D, Yap P, Desmet V. Heparan sulfate proteoglycan expression in normal human liver. Hepatology. 21:1995;950-958.
50. Murdoch AD, Liu B, Schwarting R, Tuan RS, Iozzo RV. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization. J Histochem Cytochem. 42:1994;239-249.
51. Gallai M, Kovalszky I, Knittel T, Neubauer K, Armbrust T, Ramadori G. Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells. Am J Pathol. 148:1996;1463-1471.